Pancreatic Insulin-Producing Neuroendocrine Tumor — knowledge graph · CancerIndex

Knowledge graph · Cancer

Pancreatic Insulin-Producing Neuroendocrine Tumor

subtype

Identifier: CI-CAN-00006296
Entity page: /cancer/pancreatic-insulin-producing-neuroendocrine-tumor ↗
Edges: 53

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Pancreatic Insulin-Producing Neuroendocrine Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 15
→ investigated in trials for	Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pancreatic Insulin-Producing Neuroendocrine Tumor	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants

Pancreatic Insulin-Producing Neuroendocrine Tumor studied in …STUDIED_INderived10 of 38show all (up to 200)
→ studied in	NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00001276recruiting Diagnosing and Treating Low Blood Sugar Levels · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07808879NA · recruiting Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06725693recruiting Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01916148available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07340437completed Clinical Study of 18F-Exendin-4 in Insulinoma · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05735912NA · active not recruiting EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02021604Phase 1 · recruiting Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma · condition mapped ALIAS · 38 trials mapped (6 active)	—	—	Pancreatic Insulinoma	1	Observed	clinicaltrials	graph →